Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52):...

Keywords

MedicineDupilumabNasal polypsPlaceboInternal medicinePlacebo-controlled studySinusitisClinical endpointRandomized controlled trialAsthmaChronic rhinosinusitisSurgeryDouble blindPathology

Affiliated Institutions

Related Publications

European Position Paper on Rhinosinusitis and Nasal Polyps 2020

W.J. Fokkens , Valerie J. Lund , C. Hopkins +97 more

The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012. The core objecti...

2020 Rhinology Journal 5327 citations

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

In patients with heart failure, beta-blockade has improved morbidity and left-ventricular function, but the impact on survival is uncertain. We investigated the efficacy of biso...

1999 The Lancet 4845 citations

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

James Shepherd , Gerard J. Blauw , Michael Murphy +17 more

Although statins reduce coronary and cerebrovascular morbidity and mortality in middle-aged individuals, their efficacy and safety in elderly people is not fully established. Ou...

2002 The Lancet 3358 citations

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Ann‐Lii Cheng , Yoon‐Koo Kang , Zhendong Chen +18 more

Most cases of hepatocellular carcinoma occur in the Asia-Pacific region, where chronic hepatitis B infection is an important aetiological factor. Assessing the efficacy and safe...

2008 The Lancet Oncology 5750 citations

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Andrew X. Zhu , Yoon‐Koo Kang , Chia‐Jui Yen +21 more

Patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations have poor prognosis. We aimed to establish the efficacy of ramucirumab in patien...

2019 The Lancet Oncology 1593 citations

Publication Info

Year: 2019
Type: article
Volume: 394
Issue: 10209
Pages: 1638-1650
Citations: 1335
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1335

OpenAlex

Cite This

APA Style

                            
                                
                                    Claus Bachert, 
                                
                                    Joseph K. Han, 
                                
                                    Martin Desrosiers
                                
                                et al.
                            
                            (2019). 
                            Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. 
                            The Lancet
                            , 394
                            (10209)
                            , 1638-1650.
                            https://doi.org/10.1016/s0140-6736(19)31881-1
                        

Identifiers

DOI: 10.1016/s0140-6736(19)31881-1